ALRN Rein Therapeutics, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $583K and sold $0 on the open market.
Recent ALRN insider trades
- May 27, 2026: Von Rickenbach Josef H bought 47,060 shares ($49.7K)
- Apr 30, 2026: Windsor James Brian bought 25,000 shares ($25.0K)
- Nov 14, 2025: Voss Capital, LP bought 104,183 shares ($127K)
- Oct 28, 2025: Voss Capital, LP bought 306,050 shares ($423K)
5%+ owners
- BIOS CAPITAL MANAGEMENT, LP: 10.0% (Schedule 13G/A, filed May 8, 2026)
- Funicular Funds, LP: 6.7% (Schedule 13G, filed May 7, 2026)
- Voss Capital, LP: 6.6% (Schedule 13G/A, filed Jul 14, 2026)
- ADAR1 Capital Management, LLC: 5.3% (Schedule 13G, filed Aug 14, 2026)
- Lynwood Capital Management Inc.: 5.0% (Schedule 13G/A, filed Aug 14, 2026)